Arvinas (ARVN) EBIT Margin Growth (3y) (2020 - 2026)
Arvinas (ARVN) EBIT Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Arvinas | 529.92 Mn | -84.98 Mn | - | -13,913.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,913.00 |
| Dec 31, 2025 | -58,526.00 |
| Sep 30, 2025 | 8,914.00 |
| Jun 30, 2025 | -12,452.00 |
| Mar 31, 2025 | 25,555.00 |
| Dec 31, 2024 | 4,476.00 |
| Sep 30, 2024 | 44,972.00 |
| Jun 30, 2024 | 88,024.00 |
| Mar 31, 2024 | 42,893.00 |
| Dec 31, 2023 | 100,348.00 |
| Sep 30, 2023 | 20,433.00 |
| Jun 30, 2023 | 32,389.00 |
| Mar 31, 2023 | 10,537.00 |
| Dec 31, 2022 | 26,574.00 |
| Sep 30, 2022 | -21,199.00 |
| Jun 30, 2022 | 26,406.00 |
| Mar 31, 2022 | 17,600.00 |
| Dec 31, 2021 | 34,945.00 |
| Sep 30, 2021 | -9,208.00 |
| Jun 30, 2021 | -69,311.00 |